LAM
ABBV icon

Lebenthal Asset Management’s AbbVie ABBV Stock Holding History

Lebenthal Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$9.63M Sell
147,705
-2,235
-1% -$141K 1.19% 10
2016
Q4 		$9.39M Buy
149,940
+1,026
+0.7% +$62.6K 1.21% 14
2016
Q3 		$9.39M Sell
148,914
-116
-0.1% -$7.51K 1.22% 11
2016
Q2 		$9.23M Buy
149,030
+22,655
+18% +$1.38M 1.2% 12
2016
Q1 		$7.22M Buy
+126,375
New +$7.04M 2.93% 5

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lebenthal Asset Management's ABBV Position: Q1 2017 in Review

Lebenthal Asset Management reduced its AbbVie (ABBV) stake by 1.5% in Q1 2017, selling an estimated $141K and leaving 147,705 shares worth $9.63M. The position accounts for 1.19% of the portfolio, ranked #10.

Lebenthal Asset Management first reported a position in ABBV in Q1 2016 and has held it in 5 quarters since. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Lebenthal Asset Management held 147,705 shares of AbbVie worth $9.63M as of Q1 2017.
  • Lebenthal Asset Management sold 2,235 AbbVie shares in Q1 2017, an estimated $141K.
  • AbbVie made up 1.19% of Lebenthal Asset Management's portfolio in Q1 2017, its #10 holding.
  • Lebenthal Asset Management first reported a position in AbbVie in Q1 2016 and has held it in 5 quarters since.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.